solute carrier family 35 member A2
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The SLC35A2 gene provides instructions for making an enzyme called UDP-galactose translocator (UGT). This enzyme is involved in a process called glycosylation. During this process, complex chains of sugar molecules (oligosaccharides) are added to proteins and fats (lipids). Glycosylation modifies proteins and lipids so they can fully perform their functions. The UGT enzyme transfers a simple sugar called galactose to growing oligosaccharides at a particular step in the formation of the sugar chain. Once the correct number of sugar molecules are linked together, the oligosaccharide is attached to a protein or lipid.
Video picks for GenesVideo library
Normal function
The SLC35A2 gene provides instructions for making an enzyme called UDP-galactose translocator (UGT). This enzyme is involved in a process called glycosylation. During this process, complex chains of sugar molecules (oligosaccharides) are added to proteins and fats (lipids). Glycosylation modifies proteins and lipids so they can fully perform their functions. The UGT enzyme transfers a simple sugar called galactose to growing oligosaccharides at a particular step in the formation of the sugar chain. Once the correct number of sugar molecules are linked together, the oligosaccharide is attached to a protein or lipid.
Two versions of the enzyme, known as UGT1 and UGT2, are produced from the SLC35A2 gene. These enzymes differ in only a few protein building blocks (amino acids) and can function together or separately in different areas of the cell.
Conditions referring to this gene or chromosome
Other names
solute carrier family 35 (UDP-galactose transporter), member 2
solute carrier family 35 (UDP-galactose transporter), member A2
UDP-Gal-Tr
UDP-galactose translocator
UGALT
UGAT
UGT
UGT1
UGT2
UGTL
Patient picks for Genes

Podcasts
The parental minefield
How often have you said something quite ordinary to a parent, or they’ve said something to you and suddenly the room feels like it’s about to explode? Welcome to the parental nightmare. It’s not just about conflict, it’s about what’s hidden underneath these relationships – family secrets, unspoken stories, patterns of behaviour passed from one generation to the next. In this episode Clare and Aileen explore the complex, often lifelong, relationship we have with our parents and discuss practical strategies to help you navigate this important relationship.
by Thomas Andrew Porteus, MBCS

Mental health
Not quite 'back to normal': a guide to post-pandemic family healing
When news broke in late 2019 of a virus spreading rapidly across the globe, the word ‘unprecedented’ quickly became part of everyday vocabulary in the months that followed. The outbreak of Covid-19 marked the world’s most significant public health crisis in at least a century, shaking the foundations of the one place we usually feel most secure - the home. It is no surprise that years of disrupted routines have left a lasting mark on the family unit. From the sudden loss of support networks to the blurring of boundaries between home, school, and work, the pandemic reshaped how families function. We spoke with a psychotherapist to explore these long-term psychological ripples and why reflecting on that period is essential for understanding - and healing - the family dynamic today.
by Victoria Raw

Podcasts
What are relationships anyway?
Relationships – what are they? We often think of relationships as intimate with a partner and yet we actually have hundreds of relationships with friends, family, at work, at play even with nature and beyond. Clare and Aileen kick off the season by discussing the breadth of relationships.
by Thomas Andrew Porteus, MBCS

Children's health
Pearson syndrome: how one family learned to live in the present
Pearson syndrome is a rare and serious mitochondrial disorder that typically affects infants and young children. There is currently no cure, and it is usually life-threatening. We follow one family’s journey of living with the condition, exploring how it shapes their everyday lives, the challenges they face, and what it truly means to cherish every moment.
by Victoria Raw

COVID-19
COVID-19: how to support vulnerable friends and family during the coronavirus pandemic
Current coronavirus lockdown measures are especially challenging for older people and those with mental health issues and underlying health conditions. We look at how to support vulnerable loved ones during the COVID-19 pandemic.
by Sally Turner

COVID-19
How to meet friends and family safely outdoors
Across the UK, lockdowns are easing and we're allowed to see friends and family outside (and indoors too if you live in England or Scotland). But that doesn't mean the risk of spreading COVID-19 has vanished; you still need to take precautions to keep yourself and your loved ones safe.
by Andrea Downey
Related patient information and medicines

Patient information leaflet
Cystic fibrosis
What is cystic fibrosis. Cystic fibrosis is a condition which mainly affects the lungs and pancreas but can affect other parts of the body, including the liver, nose and sinuses and sweat glands. Normally, cells in these parts of the body make mucus an... What causes cystic fibrosis. Cystic fibrosis is a genetic disorder. A genetic disorder is one.

Patient information leaflet
Planning to become pregnant
The aim is to plan ahead to reduce the risk of any harm to the baby and to reduce the risk of pregnancy complications. Women on regular medication, or who have a long-term medical condition, may need to seek medical advice to discuss any changes which may need to be made. There is a summary checklist at the end of the leaflet. However women who.

Patient information leaflet
Polycystic kidney disease
The two common problems that develop are high blood pressure High blood pressure and chronic kidney disease (CKD) Chronic kidney disease. About half of ADPKD cases lead to kidney failure requiring dialysis or a kidney transplant. What is polycystic kidney disease. A cyst is a fluid-filled sac. Cysts occur in various sizes, in various conditions.

Patient information leaflet
Glycogen storage disorders
Glycogen storage disorders are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Newer treatment possibilities.

Patient information leaflet
Glaucoma
By the age of 70, about 1 in 33 people in the UK have glaucoma. Glaucoma is unusual in people under the age of 35. Glaucoma can affect anyone but it is more common if you: Have a family history of glaucoma (if a parent, brother or sister has glaucoma, you are 2-4 times more likely than other people to develop it yourself). Have very short sight..

Patient information leaflet
Alcohol use disorder
Some people can find it very difficult to control, or stop, their drinking. What is alcohol use disorder. Alcohol use disorder means drinking alcohol in a way that causes harm. If you or a family member has alcohol use disorder then treatment and support can be provided to help you or your family member reduce or stop drinking alcohol. Alcohol use.
Further reading and references
- solute carrier family 35 member A2; MedlinePlus, National Library of Medicine.
- Dorre K, Olczak M, Wada Y, Sosicka P, Gruneberg M, Reunert J, Kurlemann G, Fiedler B, Biskup S, Hortnagel K, Rust S, Marquardt T. A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach. J Inherit Metab Dis. 2015 Sep;38(5):931-40. doi: 10.1007/s10545-015-9828-6. Epub 2015 Mar 17.
- Kimizu T, Takahashi Y, Oboshi T, Horino A, Koike T, Yoshitomi S, Mori T, Yamaguchi T, Ikeda H, Okamoto N, Nakashima M, Saitsu H, Kato M, Matsumoto N, Imai K. A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy. Brain Dev. 2017 Mar;39(3):256-260. doi: 10.1016/j.braindev.2016.09.009. Epub 2016 Oct 12.
- Kodera H, Nakamura K, Osaka H, Maegaki Y, Haginoya K, Mizumoto S, Kato M, Okamoto N, Iai M, Kondo Y, Nishiyama K, Tsurusaki Y, Nakashima M, Miyake N, Hayasaka K, Sugahara K, Yuasa I, Wada Y, Matsumoto N, Saitsu H. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. Hum Mutat. 2013 Dec;34(12):1708-14. doi: 10.1002/humu.22446. Epub 2013 Oct 15.
- Ng BG, Buckingham KJ, Raymond K, Kircher M, Turner EH, He M, Smith JD, Eroshkin A, Szybowska M, Losfeld ME, Chong JX, Kozenko M, Li C, Patterson MC, Gilbert RD, Nickerson DA, Shendure J, Bamshad MJ; University of Washington Center for Mendelian Genomics; Freeze HH. Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. Am J Hum Genet. 2013 Apr 4;92(4):632-6. doi: 10.1016/j.ajhg.2013.03.012.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

